These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10217308)

  • 21. Effect of vanadium(IV) compounds in the treatment of diabetes: in vivo and in vitro studies with vanadyl sulfate and bis(maltolato)oxovandium(IV).
    Willsky GR; Goldfine AB; Kostyniak PJ; McNeill JH; Yang LQ; Khan HR; Crans DC
    J Inorg Biochem; 2001 May; 85(1):33-42. PubMed ID: 11377693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Insulino-mimetic effects of bis (alpha-furancarboxylato) oxovanadium (IV) in vitro].
    Li YR; Gao LH; Ma YL; Niu YF; Liu WP; Li L
    Yao Xue Xue Bao; 2008 Mar; 43(3):318-22. PubMed ID: 18630272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Possible mode of action for insulinomimetic activity of vanadyl(IV) compounds in adipocytes.
    Kawabe K; Yoshikawa Y; Adachi Y; Sakurai H
    Life Sci; 2006 May; 78(24):2860-6. PubMed ID: 16337244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapeutic potential of vanadium in treating diabetes mellitus].
    Sakurai H
    Clin Calcium; 2005 Jan; 15(1):49-57. PubMed ID: 15632473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Synthesis and hypoglycemic activity of bis(L-malato)oxovanadium(IV)].
    Gorodetskiĭ VK; Tochilkin AI; Beliaeva NF; Kovel'man IR; Korovkin BF
    Biomed Khim; 2011; 57(1):133-7. PubMed ID: 21516785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new family of insulin-mimetic vanadium complexes derived from 5-carboalkoxypicolinates.
    Gätjens J; Meier B; Kiss T; Nagy EM; Buglyó P; Sakurai H; Kawabe K; Rehder D
    Chemistry; 2003 Oct; 9(20):4924-35. PubMed ID: 14562311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin mimetic effects of macrocyclic binuclear oxovanadium complexes on streptozotocin-induced experimental diabetes in rats.
    Ramachandran B; Kandaswamy M; Narayanan V; Subramanian S
    Diabetes Obes Metab; 2003 Nov; 5(6):455-61. PubMed ID: 14617232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New insights into the interactions of serum proteins with bis(maltolato)oxovanadium(IV): transport and biotransformation of insulin-enhancing vanadium pharmaceuticals.
    Liboiron BD; Thompson KH; Hanson GR; Lam E; Aebischer N; Orvig C
    J Am Chem Soc; 2005 Apr; 127(14):5104-15. PubMed ID: 15810845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, spectroscopic, structural and thermal characterizations of vanadyl(IV) adenine complex prospective as antidiabetic drug agent.
    El-Megharbel SM; Hamza RZ; Refat MS
    Spectrochim Acta A Mol Biomol Spectrosc; 2015 Jan; 135():850-64. PubMed ID: 25150436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bis(allixinato)oxovanadium(IV) complex is a potent antidiabetic agent: studies on structure-activity relationship for a series of hydroxypyrone-vanadium complexes.
    Adachi Y; Yoshida J; Kodera Y; Katoh A; Takada J; Sakurai H
    J Med Chem; 2006 Jun; 49(11):3251-6. PubMed ID: 16722643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of insulin-mimetic activities of vanadyl and zinc(II) complexes from the viewpoint of heterocyclic bidentate ligands.
    Katoh A; Matsumura Y; Yoshikawa Y; Yasui H; Sakurai H
    J Inorg Biochem; 2009 Apr; 103(4):567-74. PubMed ID: 19162327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of some vanadyl coordination compounds on the in vitro insulin release from rat pancreatic islets.
    Conconi MT; DeCarlo E; Vigolo S; Grandi C; Bandoli G; Sicolo N; Tamagno G; Parnigotto PP; Nussdorfer GG
    Horm Metab Res; 2003 Jul; 35(7):402-6. PubMed ID: 12931270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metallokinetic analysis of disposition of vanadyl complexes as insulin-mimetics in rats using BCM-ESR method.
    Yasui H; Takechi K; Sakurai H
    J Inorg Biochem; 2000 Feb; 78(3):185-96. PubMed ID: 10805174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The vanadyl (VO2+) chelate bis(acetylacetonato)oxovanadium(IV) potentiates tyrosine phosphorylation of the insulin receptor.
    Ou H; Yan L; Mustafi D; Makinen MW; Brady MJ
    J Biol Inorg Chem; 2005 Dec; 10(8):874-86. PubMed ID: 16235045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential.
    Thompson KH; Liboiron BD; Sun Y; Bellman KD; Setyawati IA; Patrick BO; Karunaratne V; Rawji G; Wheeler J; Sutton K; Bhanot S; Cassidy C; McNeill JH; Yuen VG; Orvig C
    J Biol Inorg Chem; 2003 Jan; 8(1-2):66-74. PubMed ID: 12459900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucose-lowering properties of vanadium compounds: comparison of coordination complexes with maltol or kojic acid as ligands.
    Yuen VG; Caravan P; Gelmini L; Glover N; McNeill JH; Setyawati IA; Zhou Y; Orvig C
    J Inorg Biochem; 1997 Nov; 68(2):109-16. PubMed ID: 9336969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of decavanadate and insulin enhancing vanadium compounds on glucose uptake in isolated rat adipocytes.
    Pereira MJ; Carvalho E; Eriksson JW; Crans DC; Aureliano M
    J Inorg Biochem; 2009 Dec; 103(12):1687-92. PubMed ID: 19850351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metallokinetic characteristics of antidiabetic bis(allixinato)oxovanadium(IV)-related complexes in the blood of rat.
    Yasui H; Adachi Y; Katoh A; Sakurai H
    J Biol Inorg Chem; 2007 Aug; 12(6):843-53. PubMed ID: 17503093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of nanofunctionalized oxovanadium(IV) complex and its anticancer, antidiabetic, DNA cleavage and cell imaging studies.
    Sunitha N; Isac Sobana Raj C; Sindhu Kumari B
    Int J Pharm; 2023 Sep; 644():123339. PubMed ID: 37611853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Anticancer activity of oxovanadium compounds].
    Abakumova OIu; Podobed OV; Beliaeva NF; Tochilkin AI
    Biomed Khim; 2013; 59(3):305-20. PubMed ID: 23987068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.